• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性有晶状体眼深层巩膜切除术联合丝裂霉素 C 的长期疗效。

Primary phakic deep sclerectomy augmented with mitomycin C: long-term outcomes.

机构信息

Department of Ophthalmology, Calderdale and Huddersfield NHS Trust, Huddersfield Royal Infirmary, Huddersfield, UK.

出版信息

J Glaucoma. 2011 Jan;20(1):21-7. doi: 10.1097/IJG.0b013e3181ccb926.

DOI:10.1097/IJG.0b013e3181ccb926
PMID:20179623
Abstract

AIM

To report the long-term outcomes of deep sclerectomy (DS) with intraoperative mitomycin C in eyes with no previous ocular surgery.

METHODS

One hundred ninety-four eyes of 160 consecutive patients who had primary phakic DS between August 2001 and April 2005 were included from a database on all glaucoma surgery in our department. The mean follow-up was 48±15 months (median, 49 mo).

RESULTS

The probability of a final intraocular pressure (IOP) of less than 19, 16, and 13 mm Hg without medications or needle revisions at 1 year was 85% (80% to 90%, 95% confidence intervals), 83% (78% to 88%), and 68% (62% to 75%). At 3 years was 78% (73% to 85%), 76% (60% to 82%), and 60% (53% to 67%), respectively. The probability of performing Nd:YAG laser goniopuncture (LGP) was 66% (59% to 74%) 3 years after DS. Further glaucoma surgery was undertaken in 16 eyes (8.2%). Intraoperative perforations occurred in 28 eyes (14.4%). Iris synechiae or incarceration in the goniopuncture were observed in 54 (27.8%) during follow-up and were associated with an acute symptomatic rise in IOP in 6 eyes (3.1%). Hypotony with maculopathy was seen after LGP and needling in 3 eyes (1.5%). Blebitis developed in 2 eyes (1%) after LGP and endophthalmitis in 1 eye (0.5%), which had an intraoperative perforation.

CONCLUSIONS

Mitomycin C-enhanced primary DS effectively reduces IOP in primary phakic open-angle glaucoma. Most eyes required LGP to maintain IOP control. However, complications associated with partial-thickness procedures, like bleb-related infections and hypotonic maculopathy were observed.

摘要

目的

报告术中应用丝裂霉素 C 的深层巩膜切除术(DS)在无既往眼部手术的眼中的长期疗效。

方法

从我们科室所有青光眼手术数据库中选取 2001 年 8 月至 2005 年 4 月间行初次单纯 PHACODS 的 160 例连续患者的 194 只眼。平均随访 48±15 个月(中位数,49mo)。

结果

1 年时,无需药物或针拨治疗,最终眼压(IOP)<19、16、13mmHg 的概率分别为 85%(80%90%,95%置信区间)、83%(78%88%)和 68%(62%75%)。3 年时,相应概率分别为 78%(73%85%)、76%(60%82%)和 60%(53%67%)。DS 后 3 年行 Nd:YAG 激光前房角切开术(LGP)的概率为 66%(59%~74%)。16 只眼(8.2%)行进一步青光眼手术。术中发生穿孔 28 只眼(14.4%)。随访中观察到 54 只眼(27.8%)虹膜周边黏连或嵌顿,其中 6 只眼(3.1%)发生急性症状性眼压升高。LGP 和针刺后 3 只眼(1.5%)出现黄斑病变伴低眼压,LGP 后 2 只眼(1%)发生针道炎,1 只眼(0.5%)发生眼内炎,均与术中穿孔有关。

结论

丝裂霉素 C 增强的初次 PHACODS 可有效降低原发性开角型青光眼的眼内压。大多数眼需要 LGP 来维持眼压控制。然而,仍观察到与部分厚度手术相关的并发症,如与滤泡相关的感染和低眼压性黄斑病变。

相似文献

1
Primary phakic deep sclerectomy augmented with mitomycin C: long-term outcomes.原发性有晶状体眼深层巩膜切除术联合丝裂霉素 C 的长期疗效。
J Glaucoma. 2011 Jan;20(1):21-7. doi: 10.1097/IJG.0b013e3181ccb926.
2
Mitomycin C-augmented deep sclerectomy in primary open-angle glaucoma and exfoliation glaucoma: a three-year prospective study.丝裂霉素 C 增强的原发性开角型青光眼和剥脱性青光眼深层巩膜切除术:一项为期三年的前瞻性研究。
Acta Ophthalmol. 2011 Sep;89(6):548-55. doi: 10.1111/j.1755-3768.2009.01772.x. Epub 2009 Nov 19.
3
Visante anterior segment optical coherence tomography analysis of morphologic changes after deep sclerectomy with intraoperative mitomycin-C and no implant use.使用丝裂霉素 C 术中应用和不使用植入物的深层巩膜切除术对形态变化的 Visante 眼前节光学相干断层成像分析。
J Glaucoma. 2014 Jan;23(1):e86-90. doi: 10.1097/IJG.0b013e31829ea2c8.
4
Deep sclerectomy in normal-tension glaucoma with and without mitomycin-c.正常眼压性青光眼使用与不使用丝裂霉素C的深层巩膜切除术
Acta Ophthalmol. 2014 Nov;92(7):701-6. doi: 10.1111/aos.12305. Epub 2013 Dec 21.
5
Deep sclerectomy augmented with combination of absorbable biosynthetic sodium hyaluronate scleral implant and mitomycin C or with mitomycin C versus trabeculectomy: long-term results.深板层巩膜切除术联合可吸收生物合成透明质酸钠巩膜植入物和丝裂霉素 C 或联合丝裂霉素 C 与小梁切除术的比较:长期结果。
Clin Exp Ophthalmol. 2012 May-Jun;40(4):e197-207. doi: 10.1111/j.1442-9071.2011.02611.x. Epub 2011 Aug 3.
6
Posterior revision for failed blebs: long-term outcomes.失败的囊泡后修订:长期结果。
J Glaucoma. 2011 Aug;20(6):377-82. doi: 10.1097/IJG.0b013e3181eda995.
7
Efficacy and safety of deep sclerectomy in childhood glaucoma in Saudi Arabia.沙特阿拉伯儿童青光眼深层巩膜切除术的疗效和安全性。
Acta Ophthalmol. 2014 Feb;92(1):65-70. doi: 10.1111/j.1755-3768.2012.02558.x. Epub 2012 Dec 15.
8
Deep Sclerectomy With Mitomycin C and Injectable Cross-linked Hyaluronic Acid Implant: Long-term Results.丝裂霉素C联合可注射交联透明质酸植入物的深层巩膜切除术:长期结果
J Glaucoma. 2016 Jun;25(6):e625-9. doi: 10.1097/IJG.0000000000000309.
9
Erbium:YAG laser deep sclerectomy: an alternative approach to glaucoma surgery.铒钇铝石榴石激光深层巩膜切除术:青光眼手术的一种替代方法。
Ophthalmic Surg Lasers Imaging. 2003 Sep-Oct;34(5):375-80.
10
Amniotic membrane transplantation in trabeculectomy with mitomycin C for refractory glaucoma.丝裂霉素C小梁切除术中羊膜移植治疗难治性青光眼
J Glaucoma. 2008 Jun-Jul;17(4):303-7. doi: 10.1097/IJG.0b013e31815c3a47.

引用本文的文献

1
Five-Year Outcomes of Deep Sclerectomy in Pseudoexfoliation Glaucoma Compared to Primary Open-Angle Glaucoma.与原发性开角型青光眼相比,假性剥脱性青光眼深层巩膜切除术的五年预后
J Clin Med. 2024 Dec 6;13(23):7434. doi: 10.3390/jcm13237434.
2
Outcomes of Deep Sclerectomy following Failed XEN Gel Stent Implantation in Open-Angle Glaucoma: A Prospective Study.开角型青光眼XEN凝胶支架植入失败后深层巩膜切除术的疗效:一项前瞻性研究。
J Clin Med. 2022 Aug 16;11(16):4784. doi: 10.3390/jcm11164784.
3
Rotational extraction of incarcerated iris (REII): a slit lamp technique to reduce incarcerated iris after nonpenetrating deep sclerectomy for glaucoma.
旋转性虹膜嵌顿取出术(REII):一种减少青光眼非穿透性深层巩膜切除术引起的虹膜嵌顿的裂隙灯技术。
Graefes Arch Clin Exp Ophthalmol. 2022 Oct;260(10):3331-3337. doi: 10.1007/s00417-022-05670-1. Epub 2022 Apr 20.
4
Nonpenetrating Deep Sclerectomy for Progressive Glaucoma: Long-term (5-year) Follow-up of Intraocular Pressure Control and Visual Field Survival.非穿透性深层巩膜切除术治疗进展性青光眼:眼压控制和视野存活的长期(5年)随访
J Curr Glaucoma Pract. 2020 Jan-Apr;14(1):3-9. doi: 10.5005/jp-journals-10078-1273.
5
Cataract extraction after deep sclerectomy and its effect on intraocular pressure control.深巩膜切除术(Deep Sclerectomy)后的白内障(Cataract)提取及其对眼压控制的影响。
Eye (Lond). 2019 Apr;33(4):557-563. doi: 10.1038/s41433-018-0262-5. Epub 2018 Oct 31.
6
Outcome of Primary Nonpenetrating Deep Sclerectomy in Patients with Steroid-Induced Glaucoma.激素性青光眼患者原发性非穿透性深层巩膜切除术的疗效
J Ophthalmol. 2018 Apr 4;2018:9215650. doi: 10.1155/2018/9215650. eCollection 2018.
7
Evaluation of the learning curve of non-penetrating glaucoma surgery.非穿透性青光眼手术学习曲线的评估
Int Ophthalmol. 2018 Oct;38(5):2005-2012. doi: 10.1007/s10792-017-0691-3. Epub 2017 Aug 11.
8
Nd:Yag laser goniopuncture for deep sclerectomy: efficacy and outcomes.用于深层巩膜切除术的钕:钇铝石榴石激光前房角穿刺术:疗效与结果
Graefes Arch Clin Exp Ophthalmol. 2016 Mar;254(3):535-9. doi: 10.1007/s00417-016-3271-8. Epub 2016 Jan 30.
9
A review of the efficacy of mitomycin C in glaucoma filtration surgery.丝裂霉素C在青光眼滤过手术中的疗效综述。
Clin Ophthalmol. 2015 Oct 20;9:1945-51. doi: 10.2147/OPTH.S80111. eCollection 2015.
10
Outcomes of combined phacoemulsification and deep sclerectomy: a 10-year UK single-centre study.白内障超声乳化吸除术与深层巩膜切除术联合治疗的效果:一项英国单中心10年研究
Eye (Lond). 2015 Nov;29(11):1495-503. doi: 10.1038/eye.2015.163. Epub 2015 Sep 4.